177 related articles for article (PubMed ID: 15457355)
1. Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment.
Pisanu A; Sias L; Uccheddu A
World J Surg; 2004 Aug; 28(8):761-5. PubMed ID: 15457355
[TBL] [Abstract][Full Text] [Related]
2. [Predictive factors for malignancy in Hürthle-cell thyroid neoplasia. Effect of surgical treatment].
Pisanu A; Aste L; Piu S; Cois A; Uccheddu A
Tumori; 2003; 89(4 Suppl):223-5. PubMed ID: 12903600
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology.
Boi F; Lai ML; Deias C; Piga M; Serra A; Uccheddu A; Faa G; Mariotti S
Eur J Endocrinol; 2003 Dec; 149(6):493-8. PubMed ID: 14640989
[TBL] [Abstract][Full Text] [Related]
4. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S
J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583
[TBL] [Abstract][Full Text] [Related]
5. Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes.
Pisanu A; Di Chiara B; Reccia I; Uccheddu A
World J Surg; 2010 Apr; 34(4):836-43. PubMed ID: 20041243
[TBL] [Abstract][Full Text] [Related]
6. Surgeon-performed ultrasound predictors of malignancy in patients with Hürthle cell neoplasms of the thyroid.
Parikh PP; Allan BJ; Lew JI
J Surg Res; 2013 Sep; 184(1):247-52. PubMed ID: 23535112
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of Hurthle cell tumors of the thyroid.
Chao TC; Lin JD; Chen MF
World J Surg; 2005 Feb; 29(2):164-8. PubMed ID: 15650796
[TBL] [Abstract][Full Text] [Related]
8. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative frozen-section analysis for thyroid nodules: a step toward clarity or confusion?
Huber GF; Dziegielewski P; Matthews TW; Warshawski SJ; Kmet LM; Faris P; Khalil M; Dort JC
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):874-81. PubMed ID: 17875853
[TBL] [Abstract][Full Text] [Related]
10. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of thyroid nodules--combined use of (99m)Tc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy--a retrospective cohort study.
Leidig-Bruckner G; Cichorowski G; Sattler P; Bruckner T; Sattler B
Clin Endocrinol (Oxf); 2012 May; 76(5):749-58. PubMed ID: 22078001
[TBL] [Abstract][Full Text] [Related]
12. Demographic and histological subtypes of Hurthle cell tumours of the thyroid in a South African setting.
Malith V; Bombil I; Harran N; Luvhengo TE
S Afr J Surg; 2018 Sep; 56(3):20-23. PubMed ID: 30264938
[TBL] [Abstract][Full Text] [Related]
13. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.
Giovanella L; Suriano S; Maffioli M; Ceriani L; Spriano G
Head Neck; 2010 May; 32(5):607-11. PubMed ID: 19693945
[TBL] [Abstract][Full Text] [Related]
14. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid.
Sippel RS; Elaraj DM; Khanafshar E; Zarnegar R; Kebebew E; Duh QY; Clark OH
World J Surg; 2008 May; 32(5):702-7. PubMed ID: 18224463
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
[TBL] [Abstract][Full Text] [Related]
16. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
17. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
[TBL] [Abstract][Full Text] [Related]
18. Higher body mass index and larger waist circumference may be predictors of thyroid carcinoma in patients with Hürthle-cell lesion/neoplasm fine-needle aspiration diagnosis.
Arduc A; Dogan BA; Tuna MM; Tutuncu Y; Isik S; Berker D; Guler S
Clin Endocrinol (Oxf); 2015 Sep; 83(3):405-11. PubMed ID: 25296952
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi.
Sundram FX; Mack P
Nucl Med Commun; 1995 Aug; 16(8):687-93. PubMed ID: 7491182
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
